heptyl α-D-glucopyranoside, anhydrous

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: heptyl α-D-glucopyranoside, anhydrous
• 英文别名: 1-heptyl α-D-glucopyranoside；heptyl α-D-glucopyranoside；n-heptyl α-D-glucopyranoside；(2S,3R,4S,5S,6R)-2-heptoxy-6-(hydroxymethyl)oxane-3,4,5-triol
• 化学式: C₁₃H₂₆O₆
• 分子量: 278.346
• InChiKey: NIDYWHLDTIVRJT-LBELIVKGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  19
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  99.4
• 氢给体数：
  4
• 氢受体数：
  6

上下游信息

• 上游原料

  中文名称	英文名称	CAS号	化学式	分子量
  麦芽糖	Maltose	16984-36-4	C12H22O11	342.3
  D-葡萄糖	D-glu	2280-44-6	C6H12O6	180.158
  蔗糖	Sucrose	57-50-1	C12H22O11	342.3
  β-D-葡萄糖五乙酸酯	β-D-glucose pentaacetate	604-69-3	C16H22O11	390.344

反应信息

• 作为反应物：
  描述：

  3-溴丙烯 、 heptyl α-D-glucopyranoside, anhydrous 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以60%的产率得到
  参考文献：
  名称：

  Synthesis, CI-MS Analyses and Preliminary Biological Evaluation of a Novel Library of Hydrophobic Persulfide-Spacers α-Alkyl Glycosides

  摘要：

  We report the synthesis of novel polyether-based polyols derived from simple glycosides that bear sulfur spacers in the attempt to potentially provide new antibiotics. The CI-MS demonstrated the stepwise and successive fission of the sulfide-spacer groups; however, it does not distinguish between the alditols having different arrangement of O(CH2)(3)-S(CH2)(2)OH groups. The investigated compounds exhibited antimicrobial activities against Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and antifungal activities against Candida albicans at a concentration of 1 mg / ml in DMF.

  DOI：

  10.2174/157017810790796372
• 作为产物：
  描述：

  Acetic acid (2R,3R,4S,5R,6S)-3,5-diacetoxy-2-acetoxymethyl-6-heptyloxy-tetrahydro-pyran-4-yl ester 在 三乙胺 作用下， 以 甲醇 、 水 为溶剂， 反应 24.0h， 生成 heptyl α-D-glucopyranoside, anhydrous
  参考文献：
  名称：

  Petrovic, Zorica; Konstantinovic, Stanimir; Spasojevic, Aleksandra, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2004, vol. 43, # 1, p. 132 - 134

  摘要：

  DOI：

文献信息

• [EN] PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS<br/>[FR] PEPTIDOMIMÉTIQUES POUR LE TRAITEMENT D'INFECTIONS PAR CORONAVIRUS ET PICORNAVIRUS
  申请人：UNIV EMORY

  公开号：WO2020247665A1

  公开（公告）日：2020-12-10

  Compounds, compositions and methods for preventing, treating or curing a coronavirus, picornavirus, and/or Hepeviridae virus infection in human subjects or other animal hosts. Specific viruses that can be treated include enteroviruses. In one embodiment, the compounds can be used to treat an infection with a severe acute respiratory syndrome virus, such as human coronavirus 229E, SARS, MERS, SARS-CoV-1 (OC43), and SARS-CoV- 2. In another embodiment, the methods are used to treat a patient co-infected with two or more of these viruses, or a combination of one or more of these viruses and norovirus.

  用于预防、治疗或治愈人类主体或其他动物宿主中的冠状病毒、小RNA病毒和/或肝炎病毒感染的化合物、组合物和方法。可治疗的特定病毒包括肠病毒。在一个实施例中，这些化合物可用于治疗严重急性呼吸综合征病毒感染，如人类冠状病毒229E、SARS、MERS、SARS-CoV-1（OC43）和SARS-CoV-2。在另一个实施例中，这些方法用于治疗患有两种或更多这些病毒的患者，或一种或多种这些病毒与诺如病毒的组合。
• [EN] PEPTIDOMIMETICS FOR THE TREATMENT OF NOROVIRUS INFECTION<br/>[FR] PEPTIDOMIMÉTIQUES POUR LE TRAITEMENT D'UNE INFECTION À NOROVIRUS
  申请人：UNIV EMORY

  公开号：WO2017197377A1

  公开（公告）日：2017-11-16

  The present invention is directed to compounds, compositions and methods for preventing, treating or curing Norovirus infection in human subjects or other animal hosts.

  本发明涉及用于预防、治疗或治愈人类主体或其他动物宿主中的诺如病毒感染的化合物、组合物和方法。
• [EN] ELIMINATION OF HEPATITIS B VIRUS WITH ANTIVIRAL AGENTS<br/>[FR] ÉLIMINATION DU VIRUS DE L'HÉPATITE B PAR DES AGENTS ANTIVIRAUX
  申请人：UNIV EMORY

  公开号：WO2017156255A1

  公开（公告）日：2017-09-14

  The present invention is directed to compounds, compositions and methods for preventing, treating or curing Hepatitis B (HBV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment, prevention or eradication of HBV infection.

  本发明涉及用于预防、治疗或治愈人类或其他动物宿主体内乙型肝炎（HBV）感染的化合物、组合物和方法。这些化合物还包括作为药用的可接受的盐、前药和其他衍生物，以及用于治疗、预防或根除HBV感染的药物组合物和方法。
• POLYMER STABILIZER
  申请人：KIMURA Yoshikazu

  公开号：US20100179253A1

  公开（公告）日：2010-07-15

  A polymer stabilizer comprising the following alkoxy compound: the alkoxy compound: a compound obtained by alkoxylating at least one hydroxyl group contained in a compound of the following formula (1) containing one formyl group or carbonyl group and (n− 1 ) hydroxyl groups in the molecule with an alkyl group having 1 to 12 carbon atoms: C n H 2n O n (1) (wherein, n represents an integer of 3 or more).

  一种聚合物稳定剂，包含以下烷氧基化合物：所述烷氧基化合物是通过将含有以下通式（1）中的一个甲酰基或羰基以及分子中（n-1）个羟基的化合物中的至少一个羟基进行烷氧基化而得到的化合物，其中烷基团含有1至12个碳原子：CnH2nOn（1）（其中，n代表3或以上的整数）。
• Preparation of alkyl α- and β-d-glucopyranosides, thermotropic properties and X-ray analysis
  作者：Volker Adasch、Bettina Hoffmann、Wolfgang Milius、Gerhard Platz、Gundula Voss

  DOI：10.1016/s0008-6215(98)00302-4

  日期：1998.12

  Monohydrates of heptyl to decyl α- d -glucopyranosides as obtained from product mixtures of the Fischer glucosylation were crystallized from water at the Krafft point. The results of the single-crystal X-ray analysis of anhydrous α anomers and their monohydrates provide for a better understanding of crystal formation and stability of their hydrates. The preparation of alkyl β- d -glucopyranosides—without

  摘要从Fischer葡萄糖基化产物混合物中获得的庚基到癸基α-d-吡喃葡萄糖苷一水合物在克拉夫特点从水中结晶。无水α端基异构体及其一水合物的单晶X射线分析结果可更好地理解其水合物的晶体形成和稳定性。已经描述了烷基β-d-吡喃葡萄糖苷的制备-没有伴随形成副产物α-端基异构体。已经研究了α化合物及其一水合物和β-d-吡喃葡萄糖苷的热致性质。